Your browser doesn't support javascript.
loading
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf, Andrew; Concha-Marambio, Luis; Lafontant, David-Erick; Farris, Carly M; Ma, Yihua; Urenia, Paula A; Nguyen, Hieu; Alcalay, Roy N; Chahine, Lana M; Foroud, Tatiana; Galasko, Douglas; Kieburtz, Karl; Merchant, Kalpana; Mollenhauer, Brit; Poston, Kathleen L; Seibyl, John; Simuni, Tanya; Tanner, Caroline M; Weintraub, Daniel; Videnovic, Aleksandar; Choi, Seung Ho; Kurth, Ryan; Caspell-Garcia, Chelsea; Coffey, Christopher S; Frasier, Mark; Oliveira, Luis M A; Hutten, Samantha J; Sherer, Todd; Marek, Kenneth; Soto, Claudio.
Afiliação
  • Siderowf A; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address: andrew.siderowf@pennmedicine.upenn.edu.
  • Concha-Marambio L; Research and Development Unit, Amprion, San Diego, CA, USA.
  • Lafontant DE; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Farris CM; Research and Development Unit, Amprion, San Diego, CA, USA.
  • Ma Y; Research and Development Unit, Amprion, San Diego, CA, USA.
  • Urenia PA; Research and Development Unit, Amprion, San Diego, CA, USA.
  • Nguyen H; Research and Development Unit, Amprion, San Diego, CA, USA.
  • Alcalay RN; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
  • Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
  • Foroud T; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Galasko D; Department of Neurology, University of California, San Diego, CA, USA.
  • Kieburtz K; University of Rochester Medical Center, University of Rochester, Rochester, NY, USA.
  • Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Mollenhauer B; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany; Paracelsus-Elena Klinik, Kassel, and German Center for Neurodegenerative Diseases, Göttingen, Germany.
  • Poston KL; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
  • Seibyl J; Institute for Neurodegenerative Disorders, New Haven, CT, USA.
  • Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Tanner CM; Department of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA; Parkinson's Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Weintraub D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Parkinson's Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Videnovic A; Department of Neurology, Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Choi SH; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Kurth R; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.
  • Frasier M; The Michael J Fox Foundation for Parkinson's Research, New York, NY, USA.
  • Oliveira LMA; The Michael J Fox Foundation for Parkinson's Research, New York, NY, USA.
  • Hutten SJ; The Michael J Fox Foundation for Parkinson's Research, New York, NY, USA.
  • Sherer T; The Michael J Fox Foundation for Parkinson's Research, New York, NY, USA.
  • Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA.
  • Soto C; Research and Development Unit, Amprion, San Diego, CA, USA; Department of Neurology, University of Texas McGovern Medical School at Houston, TX, USA.
Lancet Neurol ; 22(5): 407-417, 2023 05.
Article em En | MEDLINE | ID: mdl-37059509
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtorno do Comportamento do Sono REM Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Transtorno do Comportamento do Sono REM Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article